| Literature DB >> 34629708 |
Pouya Entezari1, Ahmed Gabr1, Kristie Kennedy1, Riad Salem1,2, Robert J Lewandowski1,2.
Abstract
Surgical resection has long been considered curative for patients with early-stage hepatocellular carcinoma (HCC). However, inadequate future liver remnant (FLR) renders many patients not amenable to surgery. Recently, lobar administration of yttrium-90 (Y90) radioembolization has been utilized to induce FLR hypertrophy while providing disease control, eventually facilitating resection in patients with hepatic malignancy. This has been termed "radiation lobectomy (RL)." The concept is evolving, with modified approaches combining RL and high-dose curative-intent radioembolization (radiation segmentectomy) to achieve tumor ablation. This article provides an overview of the concept and applications of RL, including technical considerations and outcomes in patients with hepatic malignancies. Thieme. All rights reserved.Entities:
Keywords: future liver remnant; hepatocellular carcinoma; interventional radiology; radiation lobectomy; radioembolization
Year: 2021 PMID: 34629708 PMCID: PMC8497080 DOI: 10.1055/s-0041-1735530
Source DB: PubMed Journal: Semin Intervent Radiol ISSN: 0739-9529 Impact factor: 1.780